Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
Phase Ib-IIA study of combined check point inhibition after autologous hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.